Advances in understanding immunity to Toxoplasma gondii

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue 2, 2009, Pages 201-210

  Tait, Elia D ^a   Hunter, Christopher A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cytokines; Microscopy; Protozoan vaccines; Toxoplasma gondii immunology

Indexed keywords

PROTOZOA; TOXOPLASMA GONDII;

EID: 65549089283     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000200013     Document Type: Article

References (140)

1. Abou-Bacar A, Pfaff AW, Georges S, Letscher-Bru V, Filisetti D, Villard O, Antoni E, Klein JP, Candolfi E 2004. Role of NK cells and γ interferon in transplacental passage of Toxoplasma gondii in a mouse model of primary infection. Infect Immun 72: 1397-1401.
2. Ajioka JW, Soldati D 2007. Preface. In JW Ajoika, D Soldati (eds.), Toxoplasma Molecular and Cellular Biology, Horizon Bioscience, Norfolk, p. 13-18.
3. Alfonzo M, Blanc D, Troadec C, Huerre M, Eliaszewicz M, Gónzalez G, Koyanagi Y, Scott-Algara D 2002. Temporary restoration of immune response against Toxoplasma gondii in HIV-infected individuals after HAART, as studied in the hu-PBMC-SCID mouse model. Clin Exp Immunol 129: 411-419.
4. Aliberti J 2005. Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma gondii. Nat Rev Immunol 5: 162-170.
5. + dendritic cells. Nat Immunol 1: 83-87.
6. Armstrong D, Young LS, Meyer RD, Blevins AH 1971. Infectious complications of neoplastic disease. Med Clin North Am 55: 729-745.
7. Artis DA, Villarino A, Silverman M, He W, Thornton EM, Mu S, Summer S, Covey TM, Huang E, Yoshida H, Koretzky G, Goldschmidt M, Wu GD, de Sauvage F, Miller HR, Saris CJ, Scott P, Hunter CA 2004. The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of Type 2 immunity. J Immunol 173: 5626-5634.
8. Aversa G, Punnonen J, Carballido JM, Cocks BG, de Vries JE 1994. CD40 ligand-CD40 interaction in Ig isotype switching in mature and immature human B cells. Semin Immunol 6: 295-301.
9. Awasthi A, Carrier Y, Peron JP, Bettelli E, Kamanaka M, Flavell RA, Kuchroo VK, Oukka M, Weiner HL 2007. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 8: 1380-1389.
10. Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S, Lee J, de Sauvage FJ, Ghilardi N 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7: 929-936.
11. Blanchard N, Gonzalez F, Schaeffer M, Joncker NT, Cheng T, Shastri AJ, Robey EA, Shastri N 2008. Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum. Nat Immunol 9: 937-944.
12. Bliss SK, Marshall AJ, Zhang Y, Denkers EY 1999. Human polymorphonuclear leukocytes produce IL-12, TNF-α, and the chemokines macrophage-inflammatory protein-1 α and -1 β in response to Toxoplasma gondii antigens. J Immunol 162: 7369-7375.
13. Boes M, Cerny J, Massol R, Op den Brouw M, Kirchhausen T, Chen J, Ploegh HL 2002. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature 418: 983-988.
14. Burke JM, Roberts CW, Hunter CA, Murray M, Alexander J 1994. Temporal differences in the expression of mRNA for IL-10 and IFN-γ in the brains and spleens of C57BL/10 mice infected with Toxoplasma gondii. Parasite Immunol 16: 305-314.
15. Candolfi E, Hunter CA, Remington JS 1995. Roles of γ interferon and other cytokines in suppression of the spleen cell proliferative response to concavalin A and Toxoplasma antigens during actue toxoplasmosis. Infect Immun 63: 751-756.
16. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospísil M, Young HA, Wolf SF, Young D, Clark SC, Trinchieri G 1991. Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 173: 869-879.
17. Chtanova T, Schaeffer M, Han SJ, van Dooren GG, Nollmann M, Herzmark P, Chan SW, Satija H, Camfield K, Aaron H, Striepen B, Robey EA 2008. Dynamics of neutrophil migration in lymph nodes during infection. Immunity 29: 487-496.
18. Collazo CM, Yap GS, Sempowski GD, Lusby KC, Tessarollo L, Woude GF, Sher A, Taylor GA 2001. Inactivation of LRG-47 and IRG-47 reveals a family of interferon γ-inducible genes with essential, pathogen-specific roles in resistance to infection. J Exp Med 194: 181-188.
19. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DA 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569.
20. Couper KN, Blount DG, Riley EM 2008. IL-10: the master regulator of immunity to infection. J Immunol 180: 5771-5777.
21. Courret N, Darche S, Sonigo P, Milon G, Buzoni-Gâtel D, Tardieux I 2006. CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 107: 309-316.
22. Dellacasa-Lindberg I, Hitziger N, Barragan A 2007. Localized recrudescence of Toxoplasma infections in the central nervous sysem of immunocompromised mice assessed by in vivo bioluminescent imaging. Microbes Infect 9: 1291-1298.
23. Derouin F, Devergie A, Auber P, Gluckman E, Beauvais B, Garin YJ, Lariviere M 1992. Toxoplasmosis in bone marrow-transplant recipients: report of seven cases and review. Clin Infect Dis 15: 267-270.
24. Desmonts G, Couvreur J 1984. Congenital toxoplasmosis. Prospective study of the outcome of pregnancy in 542 women with toxoplasmosis acquired during pregnancy. Ann Pediatr (Paris) 31: 805-809.
25. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R 1999. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counseling. Lancet 353: 1829-1833.
26. Dzierszinski FS, Hunter CA 2008. Advances in the use of genetically engineered parasites to study immunity to Toxoplasma gondii. Parasite Immunol 30: 235-244.
27. Dzierszinski F, Pepper M, Stumhofer JS, LaRosa DF, Wilson EH, Turka LA, Halonen SK, Hunter CA, Roos DS 2007. Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathways in nonprofessional and professional antigen-presenting cells. Infect Immun 75: 5200-5209.
28. Fiorentino DF, Bond MW, Mosmann TR 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170: 2081-2095.
29. Fischer A 2007. Human primary immunodeficiency diseases. Immunity 27: 835-845.
30. Fitzgerald DC, Zhang GX, El-Behi M, Fonseca-Kelly Z, Li H, Yu S, Saris CJ, Gran B, Ciric B, Rostami A 2007. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 8: 1372-1379.
31. Frenkel JK 1967. Adoptive immunity to intracellular infection. J Immunol 98: 1309-1319.
32. Frenkel JK, Amare M, Larsen W 1978. Immune competence in a patient with Hodgkin's disease and relapsing toxoplasmosis. Infection 6: 84-91.
33. Freshman MM, Merigan TC, Remington JS, Brownlee IE 1966. In vitro and in vivo antiviral action of an interferon-like substances induced by Toxoplasma gondii. Proc Soc Exp Biol Med 123: 862-866.
34. + T cell epitopes. J Infect Dis 198: 1625-1633.
35. Fuentes I, Rubio JM, Ramírez C, Alvar J 2001. Genotypic characterization of Toxoplasma gondii strains associated with human toxoplasmosis in Spain: direct analysis from clinical samples. J Clin Microbiol 39: 1566-1570.
36. Garside P, Brewer JM 2008. Real-time imaging of the cellular interactions underlying tolerance, priming and responses to infection. Immunol Rev 221: 130-146.
37. Gavrilescu LC, Butcher BA, Del Rio L, Taylor GA, Denkers EY 2004. STAT1 is essential for antimicrobial effector function but dispensable for γ interferon production during Toxoplasma gondii infection. Infect Immun 72: 1257-1264.
38. + T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol 146: 86-292.
39. Gazzinelli RT, Hayashi S, Wysocka M, Carrera L, Kuhn R, Muller W, Roberge F, Trinchieri G, Sher A 1994a. Role of IL-12 in the initiation of cell mediated immunity by Toxoplasma gondii and its regulation by IL-10 and nitric oxide. J Eukaryot Microbiol 41: 9S.
40. Gazzinelli RT, Heiny S, Wynn TA, Wolf S, Sher A 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci USA 90: 6115-6119.
41. Gazzinelli RT, Oswald IP, James SL, Sher A 1992a. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages. J Immunol 148: 1792-1796.
42. Gazzinelli RT, Wysocka M, Hayashi S, Denkers EY, Hieny S, Caspar P, Trinchieri G, Sher A 1994b. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol 153: 2533-2543.
43. + T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α. J Immunol 157: 798-805.
44. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J Immunol 149: 175-180.
45. Germain RN, Castellino F, Chieppa M, Egen JG, Huang AY, Koo LY, Qi H 2005. An extended vision for dynamic high-resolution intravital immune imaging. Semin Immunol 17: 431-441.
46. Germain RN, Miller MJ, Dustin ML, Nussenzweig MC 2006. Dynamic imaging of the immune system: progress, pitfalls and promise. Nat Rev Immunol 6: 497-507.
47. Gubbels MJ, Striepen B, Shastri N, Turkoz M, Robey EA 2005. Class I major histocompatibility complex presentation of antigens that escape from the parasitophorous vacuole of Toxoplasma gondii. Infect Immun 73: 703-711.
48. Hakes TB, Armstrong D 1983. Toxoplasmosis. Problems in diagnosis and treatment. Cancer 52: 1535-1540.
49. +γδ T-cell tolerance to foreign antigens of Toxoplasma gondii. Proc Natl Acad Sci USA 93: 5136-5140.
50. Hemmer B, Frohman E, Hartung HP, Stüve O 2006. Central nervous system infections - a potential complication of systemic immunotherapy. Curr Opin Neurol 19: 271-276.
51. Hibbert L, Pflanz S, De Waal Malefyt R, Kastelein RA 2003. IL-27 and IFN-α signal via Stat1 and Stat3 and induce T-bet and IL- 12Rβ2 in naïve T cells. J Interferon Cytokine Res 23: 513-522.
52. Hitziger N, Dellacasa I, Albiger B, Barragan A 2005. Dissemination of Toxoplasma gondii to immunopriveleged organs and role of Toll/interleukin-1 receptor signaling for host resistance assessed by in vivo bioluminescence imaging. Cell Microbiol 7: 837-848.
53. Horowitz SL, Bentson JR, Benson F, Davos I, Pressman B, Gottlieb MS 1983. CNS toxoplasmosis in acquired immunodeficiency syndrome. Arch Neurol 40: 649-652.
54. Hunter CA, Abrams JS, Beaman MH, Remington JS 1993. Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii. Infect Immun 61: 4038-4044.
55. Hunter CA, Candolfi E, Subauste C, Van Cleave V, Remington JS 1995. Studies on the role of interleukin-12 in acute murine toxoplasmosis. Immunology 84: 16-20.
56. Hunter CA, Subauste CS, Van Cleave VH, Remington JS 1994. Production of γ interferon by natural killer cells from Toxoplasma gondiiinfected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor α. Infect Immun 62: 2818-2824.
57. Israelski DM and Remington JS 1993. Toxoplasmosis in patients with cancer. Clin Infect Dis Suppl 2: S423-435.
58. - Th1 cells are the major source of hostprotective regulatory IL-10 during intracellular protozoan infection. J Exp Med 204: 273-283.
59. Jones JL, Hanson DL, Chu SY, Ciesielski CA, Kaplan JE, Ward JW, Navin TR 1996. Toxoplasmic encephalitis in HIV-infected persons: risk factors and trends. The Adult/Adolescent Spectrum of Disease Group. AIDS 10: 1393-1399.
60. Kelly CD, Russo CM, Rubin BY, Murray HW 1989. Antigen-stimulated human interferon-γ generation: role of accessory cells and their expressed or secreted products. Clin Exp Immunol 77: 397-402.
61. Khan IA, Matsuura T, Kasper LH 1994. Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect Immun 62: 1639-1642.
62. Khan IA, Matsuura T, Kasper LH 1995. IL-10 mediates immunosuppression following primary infection with Toxoplasma gondii in mice. Parasite Immunol 17: 185-195.
63. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170: 827-845.
64. Kwok LY, Lütjen S, Soltek S, Soldati D, Busch D, Deckert M, Schlüter D 2003. The induction and kinetics of antigen-specific CD8 T cells are defined by the stage specificity and compartmentalization of the antigen in murine toxoplasmosis. J Immunol 170: 1949-1957.
65. Lambert H, Hitziger N, Dellacasa I, Svensson M, Barragan A 2006. Induction of dendritic cell migration upon Toxoplasma gondii infection potentiates parasite dissemination. Cell Microbiol 8: 1611-1623.
66. Lappalainen M, Jokiranta TS, Halme L, Tynninen O, Lautenschlager I, Hedman K, Höckerstedt K, Meri S 1998. Disseminated toxoplasmosis after liver transplantation: case report and review. Clin Infect Dis 27: 1327-1328.
67. Letscher-Bru V, Pfaff AW, Abou-Bacar A, Filisetti D, Antoni E, Villard O, Klein JP, Candolfi E 2003. Vaccination with Toxoplasma gondii SAG-1 protein is protective against congenital toxoplasmosis in BALB/c mice but not in CBA/J mice. Infect Immun 71: 6615-6619.
68. Levy RM, Janssen RS, Bush TJ, Rosenblum ML 1988. Neuroepidemiology of acquired immunodeficiency syndrome. J Acquir Immun Defic Syndr 1: 31-40.
69. Lieberman LA, Banica M, Reiner SL, Hunter CA 2004. STAT1 plays a critical role in the regulation of antimicrobial effector mechanisms, but not in the development of Th1-type responses during toxoplasmosis. J Immunol 172: 457-463.
70. Lieberman LA, Hunter CA 2002. The role of cytokines and their signaling pathways in the regulation of immunity to Toxoplasma gondii. Int Rev Immunol 21: 373-403.
71. Liu CH, Fan YT, Dias A, Esper L, Corn RA, Bafica A, Machado FS, Aliberti J 2006. Cutting edge: dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice. J Immunol 177: 31-35.
72. + T cells through Stat1-dependent and -independent mechanisms. Proc Natl Acad Sci USA 100: 15047-15052.
73. Luft BJ, Brooks RG, Conley FK, McCabe RE, Remington JS 1984. Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. JAMA 252: 913-917.
74. Mallone R, Nepom GT 2004. MHC Class II tetramers and the pursuit of antigen-specific T cells: define, deviate, delete. Clin Immunol 110: 232-242.
75. Martens S, Parvanova I, Zerrahn J, Griffiths G, Schell G, Reichmann G, Howard JC 2005. Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases. PLoS Pathog 1: e24.
76. McCabe RE 2001. Antitoxoplasma chemotherapy. In HM Joynson , TG Wreghitt (eds.), Toxoplasmosis, Cambridge University Press, Cambridge, p. 319-359.
77. McKee AS, Dzierszinski F, Boes M, Roos DS, Pearce EJ 2004. Functional inactivation of immature dendritic cells by the intracellular parasite Toxoplasma gondii. J Immunol 173: 2632-2640.
78. McLeod R, Beem MO, Estes RG 1985. Lymphocyte anergy specific to Toxoplasma gondii antigens in a baby with congenital toxoplasmosis. J Clin Lab Immunol 17: 149-153.
79. Mempel TR, Scimone ML, Mora JR, von Andrian UH 2004. In vivo imaging of leukocyte trafficking in blood vessels and tissues. Curr Opin Immunol 16: 406-417.
80. Mévélec MN, Bout D, Desolme B, Marchand H, Magné R, Bruneel O, Buzoni-Gatel D 2005. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice. Vaccine 23: 4489-4499.
81. Miyazaki Y, Inoue H, Matsumura M, Matsumoto K, Nakano T, Tsuda M, Hamano S, Yoshimura A, Yoshida H 2005. Exacerbation of experimental allergic asthma by augmented Th2 responses in WSX-1-deficient mice. J Immunol 175: 2401-2407.
82. Mohrs M, Shinkai K, Mohrs K, Locksley RM 2001. Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity 15: 303-311.
83. Moore KW, de Waal Malefyt MR, Coffman RL, O'Garra A 2001. Interleukin-10 and theinterleukin-10 receptor. Annu Rev Immunol 19: 683-765.
84. Mun HS, Aosai F, Norose K, Chen M, Piao LX, Takeuchi O, Akira S, Ishikura H, Yano A 2003. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection. Int Immunol 15: 1081-1087.
85. Nathan CF, Murray HW, Wiebe ME, Rubin BY 1983. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 158: 670-689.
86. Neyer LE, Grunig G, Fort M, Remington JS, Rennick D, Hunter CA 1997. Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Infect Immun 65: 1675-1682.
87. Nicolle C 1907. Sur une piroplasmose nouvelle d'un rongeur. C R Soc Biol 63: 380-399.
88. Nicolle C, Manceaux L 1908. Sur une infection á corps de Leishman (ou organisms voisons) du gondi. C R Acad Sci 147: 763-766.
89. Nicolle C, Manceaux L 1909. Sur une protozoaire nouveau du gondi. C R Acad Sci 148: 369-372.
90. O'Garra A, Vieira P 2007. T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol 7: 425-428.
91. + T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice. Clin Exp Immunol 84: 207-212.
92. +-T-cell responses to transgenic ovalbumin-expressing Toxoplasma gondii during toxoplasmosis. Infect Immun 72: 7240-7246.
93. Pepper M, Dzierszinski F, Wilson E, Tait E, Fang Q, Yarovinsky F, Laufer TM, Roos D, Hunter CA 2008. Plasmacytoid dendritic cells are activated by Toxoplasma gondii to present antigen and produce cytokines. J Immunol 180: 6229-6236.
94. Persson EK, Agnarson AM, Lambert H, Hitziger N, Yagita H, Chambers BJ, Barragan A, Grandien A 2007. Death receptor ligation or exposure to perforin trigger rapid egress of the intracellular parasite Toxoplasma gondii. J Immunol 179: 8357-65.
95. Petersen E, Dubey JP 2001. Biology of toxoplasmosis. In DHM Joynson, TG Wreghitt (eds.), Toxoplasmosis, Cambridge University Press, Cambridge, p. 1-42.
96. Pfaff AW, Abou-Bacar A, Letscher-Bru V, Villard O, Senegas A, Mousli M, Candolfi E 2007. Cellular and molecular physiopathology of congenital toxoplasmosis: the dual role of IFN-γ. Parasitology 134: 1895-1902.
97. Pflanz S, Hibbert L, Mattson J, Rosales R, Vaiberg E, Bazan JF, Phillips JH, McClanahan TK, de Waal Malefyt R, Kastelein RA 2004. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol 172: 2225-2231.
98. + T cells. Immunity 16: 779-790.
99. Pitchenik AE, Fischl MA, Dickinson GM, Becker DM, Fournier AM, O'Connell MT, Colton RM, Spira TJ 1983. Opportunistic infections and Kaposi's sarcoma among Haitians: evidence of a new acquired immunodeficiency state. Ann Intern Med 98: 277-284.
100. Reinhardt RL, Hong S, Kang SJ, Wang ZE, Locksley RM 2006. Visualization of IL-12/23p40 in vivo reveals immunostimulatory dendritic cell migrants that promote Th1 differentiation. J Immunol 177: 1618-1627.
101. Reis e Sousa C, Hieny S, Scharton-Kersten T, Jankovic D, Charest H, Germain RN, Sher 1997. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J Exp Med 186: 1819-1829.
102. Remington JS 1974. Toxoplasmosis in the adult. Bull NY Acad Med 50: 211-227.
103. Remington JS, Krahenbuhl JL, Mendenhall JW 1972. A role for activated macrophages in resistance to infection with Toxoplasma. Infect Immun 6: 829-834.
104. Remington JS, McLeod R, Thulliez P, Desmonts G 2000. Toxoplasmosis. In JS Remington, JO Klein (eds.), Diseases of the fetus and newborn infant, W H Saunders Company, Philadelphia, p. 205-346.
105. Remington JS, Merigan TC 1968. Interferon: protection of cells infected with an intracellular protozoan (Toxoplasma gondii). Science 161: 804-806.
106. Rosas LE, Satoskar AA, Roth KM, Keiser TL, Barbi J, Hunter C, de Sauvage FJ, Satoskar AR 2006. Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to Leishmania donovani infection but develop severe liver immunopathology. Am J Pathol 168: 158-169.
107. Ruskin J, Remington JS 1976. Toxoplasmosis in the compromised host. Ann InternMed 84: 193-199.
108. Rytel MW, Jones TC 1968. Induction of interferon in mice infected with Toxoplasma gondii. Proc Soc Exp Biol Med 123: 859-862.
109. Sabin AB, Feldman HA 1948. Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoan parasite (Toxoplasma). Science 108: 660-663.
110. Saeij JP, Arrizabalaga G, Boothroyd JC 2008. A cluster of four surface antigen genes specifically expressed in bradyzoites, SAG2CDXY, plays an important role in Toxoplasma gondii persistence. Infect Immun 76: 2402-2410.
111. Saeij JP, Boyle JP, Grigg ME, Arrizabalaga G, Boothroyd JC 2005. Bioluminescence imaging of Toxoplasma gondii infection in living mice reveal dramatic differences between strains. Infect Immun 73: 695-702.
112. Scharton-Kersten TM, Yap G, Magram J, Sher A 1997. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J Exp Med 185: 1261-1273.
113. + T cell responses during microbial infection. Curr Opin Immunol 15: 436-442.
114. Shimizu S, Sugiyama N, Masutani K, Sadanaga A, Miyazaki Y, Inoue Y, Akahoshi M, Katafuchi R, Hirakata H, Harada M, Hamano S, Nakashima H, Yoshida H 2005. Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1). J Immunol 175: 7185-7192.
115. Sonoda KH, Yoshimura T, Takeda A, Ishibashi T, Hamano S, Yoshida H 2007. WSX-1 plays a significant role for the initiation of experimental autoimmune uveitis. Int Immunol 19: 93-98.
116. Splendore A 1908. Un nuovo protozoa parassita de'conigli. Incontrato nelle lesioni anatomiche d'une malattia che ricorda in molti punti il Kala-azar dell'uomo. Nota preliminaire pel. Rev Soc Sci Sao Paulo 5: 167.
117. Stetson DB, Mohrs M, Reinhardt RL, Baron JL, Wang ZE, Gapin L, Kronenberg M, Locksley RM 2003. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp Med 198: 1069-1076.
118. Striepen B, He CY, Matrajt M, Soldati D, Roos DS 1998. Expression, selection and organellar targeting of the green fluorescent protein in Toxoplasma gondii. Mol Biochem Parasitol 92: 325-338.
119. Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, Johnson LM, Villarino AV, Huang Q, Yoshimura A, Sehy D, Saris CJ, O'Shea JJ, Hennighausen L, Ernst M, Hunter CA 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 7: 937-945.
120. Stumhofer JS, Silver JS, Laurence A, Porret PM, Harris TH, Turka LA, Ernst M, Saris CJ, O'Shea JJ, Hunter CA 2007. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 8: 1363-1371.
121. Subauste CS, Wessendarp M, Sorensen RU, Leiva LE 1999. CD40- CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer. J Immunol 162: 6690-6700.
122. Sumen C, Mempel TR, Mazo IB, von Andrian UH 2004. Intravital microscopy: visualizing immunity in context. Immunity 21: 315-329.
123. Suzuki Y, Conley FK, Remington JS 1989. Importance of endogenous IFN-γ for prevention of toxoplasmic encephalitis in mice. J Immunol 143: 2045-2050.
124. Suzuki Y, Kobayashi A 1990. Induction of tolerance to Toxoplasma gondii in newborn mice by maternal antibody. Parasitol Res 76: 424-427.
125. Suzuki Y, Orellana MA, Schreiber RD, Remington JS 1988. Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science 240: 516-518.
126. + T cells in mice. J Immunol 140: 3943-3946.
127. Suzuki Y, Sher A, Yap G, Park D, Neyer LE, Liesenfeld O, Fort M, Kang H, Gufwoli E 2000. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J Immunol 164: 5375-5382.
128. Takeda K, Hamano S, Yamanaka A, Hanada T, Ishibashi T, Mak TW, Yoshimura A, Yoshida H 2003. Cutting edge: role of IL-27/WSX- 1 signnaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol 170: 4886-4890.
129. Taylor GA, Collazo CM, Yap GS, Nguyen K, Gregorio TA, Taylor LS, Eagleson B, Secrest L, Southon EA, Reid SW, Tessarollo L, Bray M, McVicar DW, Komschlies KL, Young HA, Biron CA, Sher A, Vande Woude GF 2000. Pathogen-specific loss of host resistance in mice lacking the IFN-γ-inducible gene IGTP. Proc Natl Acad Sci USA 97: 751-755.
130. Villarino A, Hibbert L, Lieberman L, Wilson E, Mak T, Yoshida H, Kastelein RA, Saris C, Hunter CA 2003. IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19: 645-655.
131. Villegas EN, Wille U, Craig L, Linsley PS, Rennick DM, Peach R, Hunter CA 2000. Blockade of costimulation prevents infectioninduced immunopathology in interleukin-10-deficient mice. Infect Immun 68: 2837-2844.
132. + lymphocytes with monoclonal antibody reactivates toxoplasmosis in the central nervous system: a model of superinfection in AIDS. J Immunol 138: 3737-3741.
133. Wensing AM, Boucher CA 2003. Worldwide transmission of drugresistant HIV. AIDS Rev 5: 140-155.
134. Wille U, Villegas EN, Craig L, Peach R, Hunter CA 2002. Contribution of interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 ligand pathways to the development of a pathological T-cell response in IL-10-deficient mice. Infect Immun 70: 6940-6947.
135. Wilson EH, Wille-Reece U, Dzierszinski F, Hunter CA 2005. A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol 165: 63-74.
136. Wirtz S, Tubbe I, Galle PR, Schild HJ, Birkenbach M, Blumberg RS, Neurath MF 2006. Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J Exp Med 203: 1875-1881.
137. Wolf A, Cowen D, Paige B 1939. Human toxoplasmosis: occurrence in infants as an encephalomyelitis. Verification by transmission to animals. Science 89: 226-227.
138. Wong SY, Remington JS 1994. Toxoplasmosis in pregnancy. Clin Infect Dis 18: 853-861.
139. Yamamoto JH, Vallochi AL, Silveira C, Filho JK, Nussenblatt RB, Cunha-Neto E, Gazzinelli RT, Belfort R Jr, Rizzo LV 2000. Discrimination between patients with acquired toxoplasmosis and congenital toxoplasmosis on the basis of the immune response to parasite antigens. J Infect Dis 181: 2018-2022.
140. Yarovinsky F, Zhang D, Andersen JF, Bannenberg GL, Serhan CN, Hayden MS, Hieny S, Sutterwala FS, Flavell RA, Ghosh S, Sher A 2005. TLR11 activation of dendritic cells by a protozoan profilin- like protein. Science 308: 1626-1629.